Challenges for the National Institute for Clinical Excellence
- PMID: 15271837
- PMCID: PMC487743
- DOI: 10.1136/bmj.329.7459.227
Challenges for the National Institute for Clinical Excellence
Abstract
So far NICE has focused on evaluating new technologies rather than existing ones. But this approach is creating inflationary pressure that the NHS cannot afford
Comment in
-
NICE and its value judgments: favourable appraisal amounts to compulsory purchase order.BMJ. 2004 Sep 25;329(7468):740-1; author reply 741. doi: 10.1136/bmj.329.7468.740-b. BMJ. 2004. PMID: 15388620 Free PMC article. No abstract available.
Comment on
-
National Institute for Clinical Excellence and its value judgments.BMJ. 2004 Jul 24;329(7459):224-7. doi: 10.1136/bmj.329.7459.224. BMJ. 2004. PMID: 15271836 Free PMC article.
References
-
- Association of the British Pharmaceutical Industry. The expert patient. London: ABPI, 1999. www.abpi.org.uk/publications/publication_details/expert_patient/power_po... (accessed 14 October 2003).
-
- Williams A. Intergenerational equity: an exploration of the fair innings. Health Economics 1997;6: 117-32. - PubMed
-
- Freemantle N, Bloor K, Eastaugh J. A fair innings for NICE? Pharmacoeconomics 2002;20: 389-91. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources